Pulse Biosciences (PLSE, $18.08) Stochastic Oscillator left the oversold zone on October 21, 2025
Tickeron - Stocks
Cogent Biosciences (COGT, $15.86) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 21, 2025
Tickeron - Stocks
Anixa Biosciences (ANIX, $4.18) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 21, 2025
Tickeron - Stocks
Pacira BioSciences (PCRX, $22.02) RSI Indicator left the oversold zone on October 21, 2025
Tickeron - Stocks
FreightCar America (RAIL, $9.58) entered Uptrend as Momentum indicator ascends above 0 level on Oct 21, 2025
Tickeron - Stocks
Pilgrim's Pride (PPC, $37.78) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 21, 2025
Tickeron - Stocks
Agios Pharmaceuticals (AGIO, $43.45) RSI Indicator left the overbought zone on October 21, 2025
Tickeron - Stocks
Emergent Biosolutions (EBS, $9.45) entered Downtrend as Momentum indicator drops below 0 level on Oct 21, 2025
Tickeron - Stocks
2,718 Shares in Neurocrine Biosciences, Inc. $NBIX Bought by Sequoia Financial Advisors LLC
MarketBeat
Samsung challenges Apple and Meta with Galaxy XR launch
DigiTimes: IT news from Asia
No Caller ID Calls Are Back Here's How to Stay Safe and Identify Them
AndroidHeadlines.com
Will TSMC's 2nm price hike force Qualcomm and MediaTek to switch orders to Samsung?
DigiTimes: IT news from Asia
T-Mobile US, Inc. (NASDAQ:TMUS) Given Average Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Novartis' Cosentyx Meets All Endpoints In Phase III Polymyalgia Rheumatica Study
Nasdaq News: Markets
iPhone 17 review: the Apple smartphone to get this year
guardian.co.uk - Technology
